$YTENQ
YIELD10 BIOSCIENCE, INC.

2019 Q2 Form 10-Q Financial Statement

#000112170219000012 Filed on May 15, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q1
Revenue $318.0K $124.0K $60.00K
YoY Change 11.58% 106.67% -81.48%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.025M $1.186M $1.276M
YoY Change -29.6% -7.05% 0.0%
% of Gross Profit
Research & Development $1.190M $1.220M $1.100M
YoY Change -5.56% 10.91% -0.9%
% of Gross Profit
Depreciation & Amortization $50.00K $50.00K $47.00K
YoY Change 0.0% 6.38% -11.32%
% of Gross Profit
Operating Expenses $1.025M $1.186M $1.276M
YoY Change -29.6% -7.05% 0.0%
Operating Profit -$1.898M -$2.285M -$2.317M
YoY Change -21.93% -1.38% 12.42%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $27.00K $25.00K $25.00K
YoY Change -28.95% 0.0% -180.65%
Pretax Income -$1.871M -$2.260M -$2.290M
YoY Change -21.72% -1.31% 9.57%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.871M -$2.260M -$2.292M
YoY Change -21.81% -1.4% 9.67%
Net Earnings / Revenue -588.36% -1822.58% -3820.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$6.032M -$8.692M -$9.542M
COMMON SHARES
Basic Shares Outstanding 12.49M shares 12.47M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.300M $6.100M $11.60M
YoY Change -55.67% -47.41% 136.73%
Cash & Equivalents $3.252M $6.065M $7.583M
Short-Term Investments $1.000M $0.00 $4.000M
Other Short-Term Assets $500.0K $500.0K $400.0K
YoY Change 25.0% 25.0% -20.0%
Inventory
Prepaid Expenses
Receivables $148.0K $45.00K $42.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.017M $6.738M $12.09M
YoY Change -50.35% -44.29% 113.71%
LONG-TERM ASSETS
Property, Plant & Equipment $1.298M $1.335M $1.526M
YoY Change -12.12% -12.52% -9.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $42.00K $71.00K $103.0K
YoY Change -57.14% -31.07% 8.42%
Total Long-Term Assets $6.139M $6.357M $7.240M
YoY Change -13.73% -12.2% 155.38%
TOTAL ASSETS
Total Short-Term Assets $5.017M $6.738M $12.09M
Total Long-Term Assets $6.139M $6.357M $7.240M
Total Assets $11.16M $13.10M $19.33M
YoY Change -35.21% -32.27% 127.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.00K $12.00K $80.00K
YoY Change 61.76% -85.0% 56.86%
Accrued Expenses $586.0K $621.0K $788.0K
YoY Change -32.72% -21.19% -68.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.506M $1.502M $1.432M
YoY Change 1.14% 4.89% -44.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.200M $5.400M $1.000M
YoY Change 477.78% 440.0% -23.08%
Total Long-Term Liabilities $5.200M $5.400M $1.000M
YoY Change 477.78% 440.0% -23.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.506M $1.502M $1.432M
Total Long-Term Liabilities $5.200M $5.400M $1.000M
Total Liabilities $6.702M $6.900M $2.405M
YoY Change 175.8% 186.9% -38.85%
SHAREHOLDERS EQUITY
Retained Earnings -$356.1M -$354.2M -$345.0M
YoY Change 2.49% 2.65% 2.86%
Common Stock $360.6M $360.5M $356.8M
YoY Change 0.99% 1.05% 4.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.454M $6.195M $11.63M
YoY Change
Total Liabilities & Shareholders Equity $11.16M $13.10M $19.33M
YoY Change -35.21% -32.27% 127.62%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$1.871M -$2.260M -$2.292M
YoY Change -21.81% -1.4% 9.67%
Depreciation, Depletion And Amortization $50.00K $50.00K $47.00K
YoY Change 0.0% 6.38% -11.32%
Cash From Operating Activities -$1.780M -$2.296M -$3.030M
YoY Change -4.3% -24.22% 24.54%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $0.00 $3.000K
YoY Change -66.67% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$1.000M $2.750M -$3.990M
YoY Change -60.0% -168.92%
Cash From Investing Activities -$1.010M $2.746M -$3.994M
YoY Change -60.08% -168.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K $2.597M $124.0K
YoY Change 1994.35%
NET CHANGE
Cash From Operating Activities -1.780M -$2.296M -$3.030M
Cash From Investing Activities -1.010M $2.746M -$3.994M
Cash From Financing Activities -20.00K $2.597M $124.0K
Net Change In Cash -2.810M $3.042M -$6.904M
YoY Change -35.99% -144.06% 183.76%
FREE CASH FLOW
Cash From Operating Activities -$1.780M -$2.296M -$3.030M
Capital Expenditures -$10.00K $0.00 $3.000K
Free Cash Flow -$1.770M -$2.296M -$3.033M
YoY Change -3.28% -24.3% 24.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
80000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
117000 USD
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
94000 USD
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45000 USD
CY2018Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
788000 USD
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001121702
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12494731 shares
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
YIELD10 BIOSCIENCE, INC.
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
680000 USD
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
621000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
234000 USD
CY2019Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
262000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-110000 USD
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-115000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
357646000 USD
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
360383000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
281000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
162000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
349000 USD
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11312467 shares
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9160552 shares
CY2016Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
29622 sqft
CY2018Q1 us-gaap Assets
Assets
19334000 USD
CY2018Q4 us-gaap Assets
Assets
12960000 USD
CY2019Q1 us-gaap Assets
Assets
13095000 USD
CY2018Q1 us-gaap Assets Current
AssetsCurrent
12094000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
6377000 USD
CY2019Q1 us-gaap Assets Current
AssetsCurrent
6738000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2746000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2746000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0 USD
CY2018Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
31000 USD
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
12000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3023000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6065000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14804000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7900000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3355000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6397000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6904000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3042000 USD
CY2019Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7433084 shares
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9185222 shares
CY2019Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9198964 shares
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10025811 shares
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12468219 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10025811 shares
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12468219 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
125000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2296000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2265000 USD
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
2377000 USD
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
9875000 USD
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
2409000 USD
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
47000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
50000 USD
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.92
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000 USD
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
98000 USD
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
140000 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-27000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-105000 USD
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-993000 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-49000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-92000 USD
CY2018Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-29000 USD
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
13000 USD
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
125000 USD
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
60000 USD
CY2018Q1 us-gaap Lease Cost
LeaseCost
265000 USD
CY2019Q1 us-gaap Lease Cost
LeaseCost
281000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8016000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3082000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
998000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
969000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
939000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1080000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
948000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1749000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
7262000 USD
CY2019Q1 us-gaap Liabilities
Liabilities
6900000 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19334000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12960000 USD
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13095000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1641000 USD
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1502000 USD
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
0 USD
CY2019Q1 us-gaap Long Term Investments
LongTermInvestments
0 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
124000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2597000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3994000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2746000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3030000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2296000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-2292000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2260000 USD
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2292000 USD
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9185000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2260000 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2317000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2285000 USD
CY2018Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
266000 USD
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
259000 USD
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
6267000 USD
CY2018Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
684000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
844000 USD
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
869000 USD
CY2018Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6149000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5621000 USD
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5398000 USD
CY2018Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5294000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4766000 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4619000 USD
CY2018Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0675
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0675
CY2018Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y4M24D
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y2M12D
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
298000 USD
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
168000 USD
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
100000 USD
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71000 USD
CY2018Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5000 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5000 USD
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 USD
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25000 USD
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
134000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25000 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2018Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
4002000 USD
CY2019Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
448000 USD
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
549000 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2597000 USD
CY2018Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
11000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
2746000 USD
CY2018Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
124000 USD
CY2019Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1526000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1385000 USD
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1335000 USD
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
317000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
332000 USD
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
332000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-351938000 USD
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-354198000 USD
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60000 USD
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
556000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124000 USD
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
307000 USD
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1276000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1186000 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
281000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
162000 USD
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
2746000 USD
CY2019Q1 us-gaap Short Term Investments
ShortTermInvestments
0 USD
CY2018Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
118000 USD
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
146000 USD
CY2018Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1772000 shares
CY2018Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
22000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
17000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2583000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
13502000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
11633000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
5698000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
6195000 USD
CY2018Q1 us-gaap Sublease Income
SubleaseIncome
119000 USD
CY2019Q1 us-gaap Sublease Income
SubleaseIncome
124000 USD
CY2018Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
66000 USD
CY2019Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
79000 USD
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9698726 shares
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10503291 shares
CY2018Q4 yten Accrued Lease Cost
AccruedLeaseCost
50000 USD
CY2019Q1 yten Accrued Lease Cost
AccruedLeaseCost
51000 USD
CY2018Q1 yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
46000 USD
CY2019Q1 yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
24000 USD
CY2018Q1 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
1101000 USD
CY2019Q1 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
1223000 USD
CY2018Q1 yten Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
-68000 USD
CY2019Q1 yten Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
-198000 USD
CY2018Q1 yten Lease Incentive Payable Noncurrent
LeaseIncentivePayableNoncurrent
0 USD
CY2018Q4 yten Lease Incentive Payable Noncurrent
LeaseIncentivePayableNoncurrent
0 USD
CY2018Q1 yten Noncash Lease Expense Income
NoncashLeaseExpenseIncome
60000 USD
CY2019Q1 yten Noncash Lease Expense Income
NoncashLeaseExpenseIncome
147000 USD
CY2016 yten Operating Leases Landlord Reimbursement For Lease Improvements
OperatingLeasesLandlordReimbursementForLeaseImprovements
889000 USD
CY2016 yten Operatingleaseslandlordreimbforleaseimprovementsadditionalpayments
Operatingleaseslandlordreimbforleaseimprovementsadditionalpayments
444000 USD
CY2018Q1 yten Private Placement Issuance Costs Incurred During Noncashor Partial Noncash Transaction
PrivatePlacementIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction
0 USD
CY2019Q1 yten Private Placement Issuance Costs Incurred During Noncashor Partial Noncash Transaction
PrivatePlacementIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction
14000 USD
CY2019Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents and investments. The Company has historically invested its cash equivalents in highly rated money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments, when purchased, are acquired in accordance with the Company&#8217;s investment policy which establishes a concentration limit per issuer.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of grant revenue and expenses during the reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001121702-19-000012-index-headers.html Edgar Link pending
0001121702-19-000012-index.html Edgar Link pending
0001121702-19-000012.txt Edgar Link pending
0001121702-19-000012-xbrl.zip Edgar Link pending
ex-311x20190331.htm Edgar Link pending
ex-312x20190331.htm Edgar Link pending
ex-321x20190331.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yten-20190331.xml Edgar Link completed
yten-20190331.xsd Edgar Link pending
yten-20190331x10q.htm Edgar Link pending
yten-20190331_cal.xml Edgar Link unprocessable
yten-20190331_def.xml Edgar Link unprocessable
yten-20190331_lab.xml Edgar Link unprocessable
yten-20190331_pre.xml Edgar Link unprocessable